Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01145222 · ClinicalTrials.gov registry record · Phase 2
Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy
A Phase 2 study, sponsored by Paion UK.
- Completed
- Registry status
- Phase 2
- Development phase
- 162
- Enrollment target
NCT01145222 is a Phase 2 study that has completed, run by Paion UK. The registered enrollment target is 162 participants.
The verdict
NCT01145222, a Phase 2 study, has completed, sponsored by Paion UK.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 162 participants
- Enrollment target
Study Summary
The purpose of this dose-response study is to assess the safety and efficacy of CNS 7056 compared with midazolam to maintain suitable sedation levels in patients undergoing colonoscopy.
Interventions
- DRUG A. CNS 7056
- DRUG B. CNS 7056
- DRUG C. CNS 7056
- DRUG D. Midazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01145222
The ClinicalTrials.gov registry entry for NCT01145222 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paion UK, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which A. CNS 7056 is the first listed.
NCT01145222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01145222 about?
NCT01145222 is a clinical study titled "Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy". The purpose of this dose-response study is to assess the safety and efficacy of CNS 7056 compared with midazolam to maintain suitable sedation levels in patients undergoing colonoscopy.
What is the current status of trial NCT01145222?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 162 participants. The study started on 2010-05. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01145222?
The interventions under investigation include: A. CNS 7056 (DRUG), B. CNS 7056 (DRUG), C. CNS 7056 (DRUG), D. Midazolam (DRUG).
Who is sponsoring clinical trial NCT01145222?
This trial is sponsored by Paion UK, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.